Targeted Medical Pharma, Inc. TRGM
0.00 USD 0.00 (+0.00%)
At close·Nov 3, 2026, 4:00 PM EST
0.00001 52-week range 0.02455
- YTD
- -90.00%
- 1 year
- -90.00%
Altman Z-Score
-24.53 Distress zone
Bankruptcy-risk model: below 1.81 distress, above 2.99 safe.
Piotroski F-Score
4 / 9 Average
Nine pass/fail tests of profitability, leverage and efficiency.
P/E -0.1×
P/S 0.1×
P/B -0.0×
P/FCF -0.3×
EV/EBITDA -3.4×
EV/Sales 1.1×
FCF Yield -303.1%
Gross Margin 60.2%
Operating Margin -38.6%
Net Margin -57.9%
ROE 23.6%
ROIC 26.6%
ROA -125.4%
Revenue -26.0%
Operating Income 22.3%
EPS (diluted) 26.7%
Free Cash Flow -263.9%
Current Ratio 0.1×
Quick Ratio 0.1×
Debt / Equity -0.4×
Net Debt / EBITDA -3.1×
Interest Coverage -1.7×
Dividend Yield 0.0%
Payout Ratio 0.0%
Annual · latest fiscal year ends 2015-12-31